Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300278
- Awardee
-
Lonza Walkersville, Inc. UEI LEEXJC9L4NF5
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,725
Award facts
- Contract value 100% obligated
- $10,724.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Walkersville, MD 21793, USA
Award details come from SAM.gov/FPDS.
About this award
Lonza Walkersville, Inc., a foreign-owned manufacturer of biological materials and laboratory equipment headquartered in Maryland, received a task order award valued at $10,724.64 under a Blanket Purchase Agreement (BPA) with the Department of Health and Human Services Office of the Director. This firm-fixed-price call order, issued on August 14, 2012, with an ultimate completion date of December 31, 2012, pertains to drugs and biologicals and represents work performed at Lonza's Walkersville, Maryland facility. The award was made without a set-aside designation, indicating open competition. As a subsidiary of the global Lonza Group, the company has established itself as a critical supplier to federal research institutions, particularly within the biomedical and life sciences sectors.
This task order is placed against Lonza Walkersville's $10 million single-award BPA with HHS that was valid through December 31, 2025, which enables streamlined procurement of biological materials, blood products, media products, laboratory supplies, and medical and scientific equipment. The company's federal contract portfolio demonstrates consistent support for research initiatives across multiple NIH institutes and centers, including the National Cancer Institute, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases. The modest contract value of approximately $10.7K is typical of individual task orders placed against this BPA, which have historically ranged from approximately $10K to $24K and supported specialized areas such as cell culture media, cell line development, and advanced scientific instrumentation for biomedical research.
Quick answers
Who was awarded contract HHSN26300278?
HHSN26300278 was awarded to Lonza Walkersville, Inc. by Office of the Director (National Institutes of Health) on August 14, 2012.
How much is contract HHSN26300278 worth?
The government has obligated $10,725 on HHSN26300278.
Is contract HHSN26300278 an order under another contract?
Yes. HHSN26300278 is a BPA call under HHSN263199900049886B, a blanket purchase agreement.
Was contract HHSN26300278 competed?
The extent of competition for HHSN26300278 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award